Peter Hall

Reader in Medical Oncology

University of Edinburgh

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter Hall is a Reader in Medical Oncology at the University of Edinburgh, UK. His research areas include the medical management of brain cavernoma, breast cancer survival and mortality among women with type 2 diabetes, and cost-effectiveness analyses related to cancer treatment. He has contributed to significant studies focusing on healthcare use associated with cancer, and the clinical impacts of various biomarkers in cancer patients.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (15)

Zosia Miedzybrodzka

University of Aberdeen

UNITED KINGDOM

Peter Hall

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Medical management and intervention (using neurosurgical resection or stereotactic radiosurgery) versus medical management alone for symptomatic brain cavernoma: the CARE pilot RCT

KERMIT: Performance indicators in electronic patient reported outcome measures: a modified Delphi

N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP)—A Prognostic Biomarker in Older and/or Frail Adults with Advanced Gastroesophageal Cancer

Long-term costs associated with healthcare use of people with cancer in Scotland

Breast cancer survival and mortality among women with type 2 diabetes: a retrospective cohort study

Breast cancer-specific survival by molecular subtype in different age groups of women in Scotland

A Cost-Effectiveness Analysis of Abemaciclib in Combination with Adjuvant Endocrine Therapy for HR+, HER2–, Node-Positive, High-Risk Early Breast Cancer

Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial

Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records

An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma

Value Of Ultrasound In Assessing Response To Neoadjuvant Chemotherapy In Breast Cancer

Cancer pain assessment and management: does an institutional approach individualise and reduce cost of care?

Intensity of care in cancer patients in the last year of life: a retrospective data linkage study

Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity

Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score test in node-positive early breast cancer

Health economic studies of colorectal cancer and the contribution of administrative data: A systematic review

The Finding My Way UK Clinical Trial: Adaptation Report and Protocol for a Replication Randomized Controlled Efficacy Trial of a Web-Based Psychological Program to Support Cancer Survivors

The impact of COVID-19 on systemic anticancer treatment delivery in Scotland

Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data

Collaborators (15)

Zosia Miedzybrodzka

Nazir I Lone

Iain Macpherson

Lee Hulbert-Williams

Katie Spencer

Vijeya Ganesan

Peter Hutchinson

Richard Turkington

Mairi McLean

Laura Ashley

Neil Stewart Coulson

Nicholas James Hulbert-Williams

Monica Leslie

Mark Baxter

Catherine Hanna

Make your next move.